Latest Safety News

Sheffield Resources delivered a standout quarter with record mineral sands shipments and positive operating cashflow from its Thunderbird Mine joint venture, setting the stage for a significant production increase by 2027.

Woodside Energy Group Ltd reported a 115% increase in net profit after tax to US$3.573 billion in 2024 despite a 6% revenue decline, driven by record production and strategic growth in LNG and new energy sectors.

Newmont Corporation’s 2024 Annual Report reveals a robust financial performance fueled by higher metal prices and the strategic acquisition of Newcrest Mining. The company also embarks on a major portfolio reshaping with planned divestitures of six non-core assets.

Iluka Resources reported a solid FY 2024 with $1.13 billion in mineral sands revenue and a net profit of $231 million, while advancing key projects like Balranald and Eneabba refinery.

Iluka Resources reported a 32% drop in net profit after tax to $231 million for 2024, while securing critical funding for its Eneabba rare earths refinery and progressing the Balranald mine development.

Nyrada Inc. posted a significant $2.46 million loss for H1 FY25, driven by increased R&D spend, while advancing its lead drug NYR-BI03 into first-in-human trials following regulatory approval.

Select Harvests Limited reported a strong financial turnaround in FY2024 with a $46 million EBITDA and a modest net profit, while facing shareholder concerns over a recent capital raise and remuneration report at its AGM.

SG Fleet Group reported a solid $41.1 million NPAT for the first half of 2025, driven by strong disposal volumes and fleet growth across Australia, New Zealand, and the UK. While profit dipped from last year, the company anticipates normalization in the second half.

MLG Oz Limited has secured a significant $75 million haulage contract with Westgold Resources, poised to generate over $25 million annually and deepen its footprint in Western Australia's Goldfields region.

Opthea has completed the final patient visit in its pivotal COAST Phase 3 trial evaluating sozinibercept combined with aflibercept for wet AMD, with topline results expected early Q2 2025.

Monadelphous Group Ltd reported a robust first half of FY2025 with revenue climbing 4.2% to $1.051 billion and net profit after tax surging 41.3%, underpinned by a strong contract pipeline and operational improvements.

Monadelphous delivered a robust first half in 2025, posting a 4.2% revenue increase to $1.051 billion and a 41.3% jump in net profit after tax, underpinned by strong contract wins and operational momentum.